Tylosin

Tylosin is a lipid of Polyketides (PK) class. Tylosin is associated with abnormalities such as Mastitis, Bovine, Infection, Bacterial Infections, Arthritis and Ileitis. The involved functions are known as Anabolism, acireductone dioxygenase [iron(II)-requiring] activity, Protein Biosynthesis, Mastitis and Methylation. Tylosin often locates in Ribosomes, Cell Wall, 50S ribosomal subunit, Ribosome Subunits, Large and Ribosome Subunits. The associated genes with Tylosin are Gene Clusters, Genome, resistance genes, Homologous Gene and HM13 gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Tylosin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tylosin?

Tylosin is suspected in Porcine ulcerative spirochetosis, Infection, Liver Abscess, Respiration Disorders, Intestinal Diseases, Mastitis, Bovine and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tylosin

MeSH term MeSH ID Detail
Digital Dermatitis D058066 3 associated lipids
Bovine Respiratory Disease Complex D048090 2 associated lipids
Pneumonia of Calves, Enzootic D048089 2 associated lipids
Desulfovibrionaceae Infections D045824 5 associated lipids
Pneumonia of Swine, Mycoplasmal D045729 2 associated lipids
Porcine Reproductive and Respiratory Syndrome D019318 4 associated lipids
Primate Diseases D018419 2 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Neisseriaceae Infections D016870 3 associated lipids
Ureaplasma Infections D016869 5 associated lipids
Per page 10 20 50 | Total 47

PubChem Associated disorders and diseases

What pathways are associated with Tylosin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tylosin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tylosin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tylosin?

There are no associated biomedical information in the current reference collection.

What genes are associated with Tylosin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tylosin?

Knock-out

Knock-out are used in the study 'A second tylosin resistance determinant, Erm B, in Arcanobacterium pyogenes.' (Jost BH et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tylosin

Download all related citations
Per page 10 20 50 100 | Total 931
Authors Title Published Journal PubMed Link
Shimi IR et al. Staphcoccomycin, a new basic macrolide antibiotic. 1979 J. Antibiot. pmid:541251
Kádár-Pauncz J et al. Isolation and structure elucidation of new antibiotics related to angolamycin. 1992 J. Antibiot. pmid:1399843
Fujiwara T et al. 19-Deformyl-4'-deoxydesmycosin (TMC-016): synthesis and biological properties of a unique 16-membered macrolide antibiotic. 1989 J. Antibiot. pmid:2500413
Kiyoshima K et al. Structure-activity relationship studies on 4''-O-acyltylosin derivatives: significance of their 23-O-mycinosyl and 4''-O-acyl moieties in antimicrobial activity against macrolide-resistant microbes. 1989 J. Antibiot. pmid:2584151
Creemer LC et al. Facile synthesis of tilmicosin and tylosin related haptens for use as protein conjugates. 2003 J. Antibiot. pmid:12870814
Kageyama S et al. Synthesis of 3-deoxy-3,4-didehydro derivatives of 5-O-mycaminosyltylonolide, 5-O-(4-deoxymycaminosyl) tylonolide, and desmycosin. 1993 J. Antibiot. pmid:8407589
Mandić Z et al. Tylosin derivatives. V. Electrochemical opening of oxirane ring. 1999 J. Antibiot. pmid:10695679
Vaughan RW et al. Isolation and characterization of two 16-membered lactones: 20-deoxorosaramicin and 20-deoxo-12,13-desepoxy-12,13-dehydrorosaramicin aglycones, from a mutant strain of Micromonospora rosaria. 1982 J. Antibiot. pmid:7076570
Tsuchiya M et al. Studies on the effects of 3-acetyl-4"-isovaleryltylosin against multiple-drug resistant strains of Staphylococcus aureus. 1981 J. Antibiot. pmid:7275812
Omura S et al. X-ray crystallography of protylonolide and absolute configuration of tylosin. 1980 J. Antibiot. pmid:7429997
Tanaka A et al. Synthesis of 4'-deoxymycaminosyl tylonolide. 1981 J. Antibiot. pmid:7309633
Tanaka A et al. Syntheses of derivatives of 4'-deoxymycaminosyl tylonolide and mycaminosyl tylonolide modified AT C-23. 1981 J. Antibiot. pmid:7309634
Tanaka A et al. Syntheses of 4'-deoxy-demycarosyl tylosin and its analogues. 1981 J. Antibiot. pmid:7309635
Inouye S et al. Modifications of a macrolide antibiotic midecamycin. II. Reaction of midecamycin and 9-acetylmidecamycin with dimethylsulfoxide and acetic anhydride. 1980 J. Antibiot. pmid:7372551
Omura S et al. Chemical modification of tylosin. Thioether derivatives of tylosin and demycarosyltylosin. 1984 J. Antibiot. pmid:6501102
Naranda A et al. New dihydro and tetrahydro derivatives of desmycosin. III. The opening of oxirane ring of 12,13-epoxydesmycosin. 1997 J. Antibiot. pmid:9402992
Fish SA and Cundliffe E Structure-activity studies of tylosin-related macrolides. 1996 J. Antibiot. pmid:8968399
Tsutsui A et al. Antimalarial C-9 oxime derivatives from desmycosin, produced by click chemistry. 2013 J. Antibiot. pmid:23232930
Cacciapuoti AF et al. Microbiological and pharmacokinetic studies of acyl demycinosyltylosin and related tylosin derivatives. 1990 J. Antibiot. pmid:2145254
Kageyama S et al. Synthesis of 3,4'-dideoxymycaminosyl tylonolide, a novel type of macrolide derivative. 1992 J. Antibiot. pmid:1548187
Ruggeri C et al. Synthesis and antibacterial activity of 9-O-[(2-methoxyethoxy)methyl]-oximes of tylosin and demycarosyltylosin. 1989 J. Antibiot. pmid:2793598
Marshall VP et al. Enzymic inactivation of lincosaminide and macrolide antibiotics: divalent metal cation and coenzyme specificities. 1989 J. Antibiot. pmid:2722691
Omura S et al. Effect of ammonium ion, inorganic phosphate and amino acids on the biosynthesis of protylonolide, a precursor of tylosin aglycone. 1984 J. Antibiot. pmid:6735923
Omura S et al. Valine as a precursor of n-butyrate unit in the biosynthesis of macrolide aglycone. 1983 J. Antibiot. pmid:6874580
Wilson VT and Cundliffe E Molecular analysis of tlrB, an antibiotic-resistance gene from tylosin-producing Streptomyces fradiae, and discovery of a novel resistance mechanism. 1999 J. Antibiot. pmid:10348045
Ose EE In vitro antibacterial properties of EL-870, a new semi-synthetic macrolide antibiotic. 1987 J. Antibiot. pmid:3570967
Wiley PF et al. Enzymatic phosphorylation of macrolide antibiotics. 1987 J. Antibiot. pmid:3570968
Kiyoshima K et al. New tylosin analogs produced by mutants of Streptomyces fradiae. 1987 J. Antibiot. pmid:3680024
Takeuchi T et al. 4''-O-(4-methoxyphenyl)-acetyltylosin, a new macrolide derivative of therapeutic importance. 1987 J. Antibiot. pmid:3680047
Morisaki N et al. Glycosylative inactivation of chalcomycin and tylosin by a clinically isolated Nocardia asteroides strain. 2001 J. Antibiot. pmid:11302489
Jacob ME et al. Effects of feeding wet corn distillers grains with solubles with or without monensin and tylosin on the prevalence and antimicrobial susceptibilities of fecal foodborne pathogenic and commensal bacteria in feedlot cattle. 2008 J. Anim. Sci. pmid:18192558
Duff GC et al. Effects of lasalocid and monensin plus tylosin on serum metabolic hormones and clinical chemistry profiles of beef steers fed a 90% concentrate diet. 1994 J. Anim. Sci. pmid:8014140
Maxwell CL et al. The effects of technology use in feedlot production systems on feedlot performance and carcass characteristics. 2015 J. Anim. Sci. pmid:26020911
Pilcher CM et al. The interaction of fiber, supplied by distillers dried grains with solubles, with an antimicrobial and a nutrient partitioning agent on nitrogen balance, water utilization, and energy digestibility in finishing pigs. 2015 J. Anim. Sci. pmid:26020889
Mercadante VR et al. Effects of anti-phospholipase A(2) antibody supplementation on dry matter intake feed efficiency, acute phase response, and blood differentials of steers fed forage- and grain-based diets. 2015 J. Anim. Sci. pmid:26020758
Maxwell CL et al. Effects of beef production system on animal performance and carcass characteristics. 2014 J. Anim. Sci. pmid:25403195
Tennant TC et al. Comparison of tulathromycin and tilmicosin on the prevalence and severity of bovine respiratory disease in feedlot cattle in association with feedlot performance, carcass characteristics, and economic factors. 2014 J. Anim. Sci. pmid:25349362
Beck P et al. Additive effects of growth promoting technologies on performance of grazing steers and economics of the wheat pasture enterprise. 2014 J. Anim. Sci. pmid:24492552
DiLorenzo N et al. Effects of feeding polyclonal antibody preparations on ruminal bacterial populations and ruminal pH of steers fed high-grain diets. 2006 J. Anim. Sci. pmid:16864880
Abell KM et al. A mixed treatment comparison meta-analysis of metaphylaxis treatments for bovine respiratory disease in beef cattle. 2017 J. Anim. Sci. pmid:28380607
Bosi P et al. Feed supplemented with 3 different antibiotics improved food intake and decreased the activation of the humoral immune response in healthy weaned pigs but had differing effects on intestinal microbiota. 2011 J. Anim. Sci. pmid:21724943
Cooprider KL et al. Feedlot efficiency implications on greenhouse gas emissions and sustainability. 2011 J. Anim. Sci. pmid:21398565
Meyer NF et al. Effect of essential oils, tylosin, and monensin on finishing steer performance, carcass characteristics, liver abscesses, ruminal fermentation, and digestibility. 2009 J. Anim. Sci. pmid:19359504
Stackhouse-Lawson KR et al. Growth promoting technologies reduce greenhouse gas, alcohol, and ammonia emissions from feedlot cattle. 2013 J. Anim. Sci. pmid:24085413
Weber TE and Kerr BJ Effect of sodium butyrate on growth performance and response to lipopolysaccharide in weanling pigs. 2008 J. Anim. Sci. pmid:17998428
Nagaraja TG et al. Bacterial flora of liver abscesses in feedlot cattle fed tylosin or no tylosin. 1999 J. Anim. Sci. pmid:10328365
Morris FE et al. Effect of rotating monensin plus tylosin and lasalocid on performance, ruminal fermentation, and site and extent of digestion in feedlot cattle. 1990 J. Anim. Sci. pmid:2254185
Brumm MC and Peo ER Effect of receiving diets containing alfalfa and certain feed additives on performance of feeder pigs transported long distances. 1985 J. Anim. Sci. pmid:4030523
Potter EL et al. Effect of monensin and tylosin on average daily gain, feed efficiency and liver abscess incidence in feedlot cattle. 1985 J. Anim. Sci. pmid:4077750
Han H et al. Carbohydrate fermentation and nitrogen metabolism of a finishing beef diet by ruminal microbes in continuous cultures as affected by ethoxyquin and(or) supplementation of monensin and tylosin. 2002 J. Anim. Sci. pmid:12002320